Platz KP et al. |
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. |
1994 |
Transplant. Proc. |
pmid:7527952
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Tze WJ et al. |
Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513471
|
Gołębiewska J et al. |
Tako-tsubo cardiomyopathy on the first day after renal transplantation - case report and literature review. |
2014 |
Transplant. Proc. |
pmid:25380951
|
Yabuuchi H et al. |
Prominent prolongation of islet xenograft survival in combination therapy with FK 506 and 15-deoxyspergualin. |
1991 |
Transplant. Proc. |
pmid:1703718
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Kanter J et al. |
Cytomegalovirus infection renal transplant recipients: risk factors and outcome. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715860
|
Bilbao I et al. |
Indications and management of everolimus after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715864
|
TuÄŸcu M et al. |
Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26093759
|
Facundo C et al. |
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959203
|
GarcÃa-Meseguer C et al. |
Efficacy and safety of basiliximab in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959206
|
Rafael-Valdivia L et al. |
How long should initiation of calcineurin inhibitors be delayed to protect renal function in liver transplantation? |
2011 |
Transplant. Proc. |
pmid:21486577
|
Charco R et al. |
A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21486582
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Wiesner RH |
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. |
1998 |
Transplant. Proc. |
pmid:9636565
|
Santos T et al. |
New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. |
2015 |
Transplant. Proc. |
pmid:26036483
|
Luk JM et al. |
Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. |
2000 |
Transplant. Proc. |
pmid:11120045
|
Higuchi K et al. |
FK506 induces the atrophy of enteric ganglia in small bowel transplantation, which can be prevented by the neuropeptide bombesin. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908293
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Mayer AD |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study. |
1999 |
Transplant. Proc. |
pmid:10576038
|
Farghali H et al. |
FK 506 modulates D-galactosamine-induced hepatitis in rats. |
1991 |
Transplant. Proc. |
pmid:1721285
|
Harrison DM et al. |
Reduction in hospital stay after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623451
|
Kaplinsky E et al. |
Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146455
|
Andrews WS et al. |
Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623452
|
MartÃn-Mateos RM et al. |
Initial immunosuppression with or without basiliximab: a comparative study. |
2012 |
Transplant. Proc. |
pmid:23146457
|
Barten MJ et al. |
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16387162
|
Chueh SC et al. |
Pharmacokinetic variability of sirolimus in Taiwanese renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518745
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Pan F et al. |
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. |
1994 |
Transplant. Proc. |
pmid:7518113
|
Valdivia LA et al. |
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. |
1994 |
Transplant. Proc. |
pmid:7518123
|
Lischke R et al. |
Initial single-center experience with sirolimus after lung transplantation. |
2006 |
Transplant. Proc. |
pmid:17112886
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Klintmalm GB et al. |
Rejection: FK 506 for rescue or maintenance. |
1993 |
Transplant. Proc. |
pmid:7682356
|
Mor E et al. |
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. |
1995 |
Transplant. Proc. |
pmid:7533363
|
Matsuura T et al. |
Beneficial immunosuppressive effect of combined use of FK 506 and cyclosporine assessed by proliferative responses of cloned human T cells. |
1991 |
Transplant. Proc. |
pmid:1721316
|
Jiang H et al. |
Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro. |
1991 |
Transplant. Proc. |
pmid:1721317
|
Moreno Gonzales M et al. |
Sublingual Tacrolimus in Liver Transplantation: A Valid Option? |
|
Transplant. Proc. |
pmid:27569953
|
Wang SS et al. |
Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus. |
2008 |
Transplant. Proc. |
pmid:18929814
|
Schumacher G et al. |
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth. |
2002 |
Transplant. Proc. |
pmid:12176410
|
Li J et al. |
Regulatory effect of FK506 on CD152 and PD-1 in the liver allorecipients. |
2008 |
Transplant. Proc. |
pmid:18589137
|
Ennaifer R et al. |
Nodular hyperplasia of the gastrointestinal tract after liver transplantation: role of immunosuppressive therapy? A case report. |
2015 |
Transplant. Proc. |
pmid:25891739
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Takaya S et al. |
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. |
1991 |
Transplant. Proc. |
pmid:1721348
|
Bouchta NB et al. |
Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation. |
2005 |
Transplant. Proc. |
pmid:15919485
|
Wasiak D et al. |
Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report. |
2016 |
Transplant. Proc. |
pmid:27496507
|
Cardinal H et al. |
The evolution of kidney function after lung transplantation: a retrospective cohort study. |
2009 |
Transplant. Proc. |
pmid:19857746
|
Numakura K et al. |
Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919487
|
Langrehr JM et al. |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. |
2002 |
Transplant. Proc. |
pmid:12176487
|
Varo E et al. |
Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176488
|
De Ruvo N et al. |
Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182760
|
Takahashi N et al. |
Nitric oxide generation in renal allograft recipients. |
1998 |
Transplant. Proc. |
pmid:9838306
|
Zucker K et al. |
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123027
|
Sellers M et al. |
Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123065
|
Ronchetti F et al. |
Mucosal hyaluronic acid quantification in small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907950
|
Costa A et al. |
Stimulatory effect of FK506 and erythromycin on pig intestinal motility. |
1996 |
Transplant. Proc. |
pmid:8907957
|
Sun CK et al. |
Intensive care after orthotopic liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7520627
|
Sato K et al. |
Effectiveness of triple regimen immunosuppression in canine pancreatic allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7520628
|
Yin DP et al. |
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. |
2000 |
Transplant. Proc. |
pmid:10936320
|
Prasad SJ et al. |
In vitro effects of cyclosporine and FK 506 on the renal cortex. |
1991 |
Transplant. Proc. |
pmid:1721380
|
Witzigmann H et al. |
Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results. |
2002 |
Transplant. Proc. |
pmid:12493472
|
Kusne S et al. |
Early infections in kidney transplant recipients under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703364
|
Yamada K et al. |
Short-term FK 506-induced morphological changes in rat kidneys. |
1991 |
Transplant. Proc. |
pmid:1721381
|
Nanmoku K et al. |
Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy. |
2008 |
Transplant. Proc. |
pmid:18790241
|
Citterio F et al. |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176535
|
Terakura M et al. |
Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083380
|
Hariharan S et al. |
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123462
|
Jonas S et al. |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962257
|
Madariaga JR et al. |
The long-term efficacy of multivisceral transplantation. |
2000 |
Transplant. Proc. |
pmid:10995918
|
Fishbein T et al. |
Isolated intestinal transplantation in adults with nonreconstructible GI tracts. |
2000 |
Transplant. Proc. |
pmid:10995925
|
Tze WJ et al. |
Long-term survival of islet allografts in diabetic rats treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721411
|
Shinozuka N et al. |
Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8658649
|
Wang X et al. |
Intraportal FK 506 improves intrahepatic islet allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721412
|
Ju MK et al. |
Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay? |
2008 |
Transplant. Proc. |
pmid:19100463
|
McCarter JF et al. |
FK 506 protects brain tissue in animal models of stroke. |
2001 |
Transplant. Proc. |
pmid:11377571
|
Wen J et al. |
Tripterygium wilfordii hook f increase the blood concentration of tacrolimus. |
2008 |
Transplant. Proc. |
pmid:19100464
|
Baran DA et al. |
Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176609
|
van Gelder T et al. |
ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications. |
2001 |
Transplant. Proc. |
pmid:11377580
|
Fieguth HG et al. |
Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation. |
2002 |
Transplant. Proc. |
pmid:12176613
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Dudley CR |
Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267179
|
Navaneethan SD et al. |
Tacrolimus-associated hypomagnesemia in renal transplant recipients. |
2006 |
Transplant. Proc. |
pmid:16797291
|
Ettenger RB |
New immunosuppressive agents in pediatric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723350
|
Falkenstein K and Dunn S |
Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9723354
|
Chu Z et al. |
Influence of immunosuppressive drugs on the development of CD4(+)CD25(high) Foxp3(+) T cells in liver transplant recipients. |
2010 |
Transplant. Proc. |
pmid:20832552
|
Hasegawa S et al. |
FK 506 and cyclosporine: effects and side effects in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721443
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
Thiru S et al. |
Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445086
|
Morales J et al. |
Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells. |
2008 |
Transplant. Proc. |
pmid:19010240
|
Wang CH et al. |
Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral. |
2004 |
Transplant. Proc. |
pmid:15561257
|
Aidong W et al. |
Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation. |
2004 |
Transplant. Proc. |
pmid:15561258
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
EscartÃn A et al. |
Orthotopic small bowel transplantation in pigs without steroids. |
1999 |
Transplant. Proc. |
pmid:10500720
|
Ribas Y et al. |
Lack of accommodation after long-term survival of hamster xenografts in rats. |
1999 |
Transplant. Proc. |
pmid:10500752
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Müller V et al. |
Effect of mycophenolate mofetil on the in vivo infiltration of lymphocytes in the rat remnant kidney. |
1998 |
Transplant. Proc. |
pmid:9636396
|
Granot E et al. |
Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation. |
2000 |
Transplant. Proc. |
pmid:10856551
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|